Evaluating medication effects outside of clinical trials: new-user designs - PubMed (original) (raw)
. 2003 Nov 1;158(9):915-20.
doi: 10.1093/aje/kwg231.
Affiliations
- PMID: 14585769
- DOI: 10.1093/aje/kwg231
Evaluating medication effects outside of clinical trials: new-user designs
Wayne A Ray. Am J Epidemiol. 2003.
Abstract
Recent clinical trials demonstrating that hormone replacement therapy (HRT) does not prevent coronary heart disease in women have again raised doubts concerning observational studies. Although much of the explanation probably lies in what might be called the "healthy HRT user" effect, another contributing factor may be that most observational studies included many prevalent users: women taking HRT for some time before study follow-up began. This practice can cause two types of bias, both of which plausibly may have contributed to the discrepancy between observational and randomized studies. First, prevalent users are "survivors" of the early period of pharmacotherapy, which can introduce substantial bias if risk varies with time, just as in studies of operative procedures that enroll patients after they have survived surgery. This article provides several examples of medications for which the hazard function varies with time and thus would be subject to prevalent user bias. Second, covariates for drug users at study entry often are plausibly affected by the drug itself. Investigators often do not adjust for these factors on the causal pathway, which may introduce confounding. A new-user design eliminates these biases by restricting the analysis to persons under observation at the start of the current course of treatment. This article thus argues that such designs should be used more frequently in pharmacoepidemiology.
Similar articles
- New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
Luijken K, Spekreijse JJ, van Smeden M, Gardarsdottir H, Groenwold RHH. Luijken K, et al. Pharmacoepidemiol Drug Saf. 2021 Jul;30(7):960-974. doi: 10.1002/pds.5258. Epub 2021 May 10. Pharmacoepidemiol Drug Saf. 2021. PMID: 33899305 Free PMC article. Review. - Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.
Acton EK, Willis AW, Hennessy S. Acton EK, et al. Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):9-18. doi: 10.1002/pds.5547. Epub 2022 Oct 20. Pharmacoepidemiol Drug Saf. 2023. PMID: 36216785 Free PMC article. - Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
Suissa S, Moodie EE, Dell'Aniello S. Suissa S, et al. Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):459-468. doi: 10.1002/pds.4107. Epub 2016 Sep 9. Pharmacoepidemiol Drug Saf. 2017. PMID: 27610604 - Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H, Norpoth T, Michaels MA. Rekers H, et al. Eur J Contracept Reprod Health Care. 1996 Mar-May;1(1):21-30. Eur J Contracept Reprod Health Care. 1996. PMID: 9678134 Review.
Cited by
- Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis.
Cao Z, Li Q, Wu J, Li Y. Cao Z, et al. Inflammopharmacology. 2024 Aug 11. doi: 10.1007/s10787-024-01542-8. Online ahead of print. Inflammopharmacology. 2024. PMID: 39127978 - Pancreatic cancer risk in diabetic patients using the Japanese Regional Insurance Claims.
Satoh T, Nakatani E, Ariyasu H, Kawaguchi S, Ohno K, Itoh H, Hayashi K, Usui T. Satoh T, et al. Sci Rep. 2024 Jul 23;14(1):16958. doi: 10.1038/s41598-024-67505-9. Sci Rep. 2024. PMID: 39043788 Free PMC article. - Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population.
Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Wang W, et al. Nat Commun. 2024 May 28;15(1):4548. doi: 10.1038/s41467-024-48780-6. Nat Commun. 2024. PMID: 38806481 Free PMC article. - Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women.
Hoffman SR, Smith JS, Funk MJ, Hudgens MG, Poole C, Nicholson WK, Baird DD, Harmon QE. Hoffman SR, et al. PLoS One. 2024 May 23;19(5):e0303823. doi: 10.1371/journal.pone.0303823. eCollection 2024. PLoS One. 2024. PMID: 38781223 Free PMC article. - Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults.
D'Aiuto C, Lunghi C, Guénette L, Berbiche D, Bertrand K, Vasiliadis HM. D'Aiuto C, et al. Drug Saf. 2024 Aug;47(8):799-807. doi: 10.1007/s40264-024-01429-1. Epub 2024 May 9. Drug Saf. 2024. PMID: 38722482
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical